Document is current
Any future updates will be listed below
-
Authors
Lädermann, Alexandre
Pernoud, Anthony
Cochard, Blaise
Bothorel, Hugo
-
Funding
Funding for this research was provided by:
Fondation de La Tour pour la recherche et l'enseignement en orthopédie, médecine du sport, traumatologie et imagerie de l'appareil moteur (FORE 2024-30)
University of Geneva
- License Information
-
More Information
Article History
Received: 9 September 2024
Accepted: 16 July 2025
First Online: 4 August 2025
Declarations
:
: The trial is currently in the enrolment phase. The protocol was approved by the ethical committee board (CCER 2023–00111) in March 2023 and registered on clinicaltrial.gov (NCT05807854) in March 2023. For all patients agreeing to participate, a written informed consent will be obtained.
: Informed consent from was approved by the ethical committee board (CCER 2023–00111) in March 2023. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are available from the corresponding author on request.
: AL is a paid consultant for Stryker, Medacta, and Arthrex. He receives royalties from Stryker. He is the founder of FORE, BeeMed, and Med4Cast. He owns stock options of Medacta, BeeMed, and FollowHealth. The other authors declare that they have no competing interests.
